Literature DB >> 15837294

Novel 4-amino-furo[2,3-d]pyrimidines as Tie-2 and VEGFR2 dual inhibitors.

Yasushi Miyazaki1, Shinichiro Matsunaga, Jun Tang, Yutaka Maeda, Masato Nakano, Rocher J Philippe, Megumi Shibahara, Wei Liu, Hideyuki Sato, Liping Wang, Robert T Nolte.   

Abstract

A novel class of furo[2,3-d]pyrimidines has been discovered as potent dual inhibitors of Tie-2 and VEGFR2 receptor tyrosine kinases (TK) and a diarylurea moiety at 5-position shows remarkably enhanced activity against both enzymes. One of the most active compounds, 4-amino-3-(4-((2-fluoro-5-(trifluoromethyl)phenyl)amino-carbonylamino)phenyl)-2-(4-methoxyphenyl)furo[2,3-d]pyrimidine (7k) is <3 nM on both TK receptors and the activity is rationalized based on the X-ray crystal structure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837294     DOI: 10.1016/j.bmcl.2005.03.034

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis.

Authors:  J Kankanala; A M Latham; A P Johnson; S Homer-Vanniasinkam; C W G Fishwick; S Ponnambalam
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  N⁴-(3-Bromophenyl)-7-(substituted benzyl) pyrrolo[2,3-d]pyrimidines as potent multiple receptor tyrosine kinase inhibitors: design, synthesis, and in vivo evaluation.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Jie Yang; Jessica E Thorpe; Michael A Ihnat
Journal:  Bioorg Med Chem       Date:  2012-02-04       Impact factor: 3.641

3.  Can we use docking and scoring for hit-to-lead optimization?

Authors:  Istvan J Enyedy; William J Egan
Journal:  J Comput Aided Mol Des       Date:  2008-01-09       Impact factor: 3.686

4.  Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors.

Authors:  Daniel Mucs; Richard A Bryce; Pascal Bonnet
Journal:  J Comput Aided Mol Des       Date:  2011-06-17       Impact factor: 3.686

5.  Synthesis and biological activity of 5-chloro-N⁴-substituted phenyl-9H-pyrimido[4,5-b]indole-2,4-diamines as vascular endothelial growth factor receptor-2 inhibitors and antiangiogenic agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Bryan C Disch; Jessica E Thorpe; Anja Bastian; Michael A Ihnat
Journal:  Bioorg Med Chem       Date:  2013-01-31       Impact factor: 3.641

6.  4-(4-Fluoro-phen-yl)-6-(2-fur-yl)pyrimidin-2-amine.

Authors:  Mujahid Hussain Bukhari; Hamid Latif Siddiqui; Muhammad Ashraf Chaudhary; Tanvir Hussain; Masood Parvez
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-05-03

7.  A reinvestigation of the acid-promoted heterocyclization of 2-(2-oxo-2-arylethyl)malononitriles in the presence of amines.

Authors:  Carla Martins; Ana Eleutério; M Carmo Carreiras; Abdelouahid Samadi; Elena Soriano; Rafael Léon; José Marco-Contelles
Journal:  Mol Divers       Date:  2009-03-13       Impact factor: 2.943

8.  Single agents with designed combination chemotherapy potential: synthesis and evaluation of substituted pyrimido[4,5-b]indoles as receptor tyrosine kinase and thymidylate synthase inhibitors and as antitumor agents.

Authors:  Aleem Gangjee; Nilesh Zaware; Sudhir Raghavan; Michael Ihnat; Satyendra Shenoy; Roy L Kisliuk
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

Review 9.  Cheminfomatic-based Drug Discovery of Human Tyrosine Kinase Inhibitors.

Authors:  Terry-Elinor Reid; Joseph M Fortunak; Anthony Wutoh; Xiang Simon Wang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

10.  The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents.

Authors:  Xin Zhang; Sudhir Raghavan; Michael Ihnat; Jessica E Thorpe; Bryan C Disch; Anja Bastian; Lora C Bailey-Downs; Nicholas F Dybdal-Hargreaves; Cristina C Rohena; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem       Date:  2014-05-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.